- Wednesday, October 10
- 9:15 AM - 10:30 AM
Autoimmune diseases are the second leading cause of chronic illness, with 80-100 types of disease reported, and affecting approximately 50 million patients in the US. This activity will feature two nationally prominent leaders in rheumatology who are experts in autoimmune diseases biomarker science and clinical management. They will discuss the current trends in autoimmune disorder diagnosis by primary care providers, including etiology, risk assessment, and importance of early diagnosis.
Discuss the current trends in autoimmune disorder diagnosis by primary care providers, including etiology, risk assessment, and importance of early diagnosis
Relate the clinical and genetic evidence for the association of biomarkers such as antinuclear antibody (ANA) presence and proper testing algorithms
Ability to diagnosis rheumatic diseases when ANA testing is negative
Gain competence in using and evaluating current biomarkers for diagnosis of early RA
Discuss the new types of biomarker testing available for diagnosing rheumatic diseases and how to interpret the results
Robert A. Baldor received his MD from the University of Vermont College of Medicine and completed his family practice residency at the University of Massachusetts/ Hahnemann Family Health Center. Dr. Baldor is currently Professor and Sr. Vice-Chairma...